Abstract:Currently there is no reliable nomogram to predict the probabilities of having indications for adjuvant prostate radiation therapy for patients with clinically localized prostate cancer who plans radical prostatectomy (RP). The purpose of this study is to examine our cohort of RP patients and to develop the above nomogram through the correlation of pretreatment PSA, clinical T stage and biopsy Gleason Score with adverse features such as extraprostatic extension, positive margin(s), and Gleason Score 8-10 that are commonly indicated for adjuvant radiation therapy. We analyzed 1440 RP patients between August, 2000 and August, 2015 at our hospital. Patients who had a history of neoadjuvant hormonal therapy, or transurethral resection of the prostate (TURP) were excluded from this analysis. A total of 627 patients were eligible for analysis. Average age was 66 years. All patients had a preoperative PSA level, biopsy Gleason Score, pelvic MRI and clinical T stage (TNM 2009 classification). Preoperative PSA level clinical T stage (T2a/b, T2c, T3a, T3b), and biopsy Gleason score (5 to 6, 3+4 = 7, 4 + 3 = 7, 8 to 10) were recorded as preoperative predictors. These predictors were used in multivariable logistic regression analysis based nomograms to estimate the probabilities of extraprostatic extension, positive margin(s), Gleason Score 8-10 after RP, respectively. The predictive accuracy and discriminative ability of the nomogram were determined by concordance index (C-index) and calibration curve. Analyses were performed with open-source statistical software (version 3.2.1). Preoperatively, 41% of patients had a PSA level between 10 and 20 ng/mL, 80% had T2, and 50% had biopsy Gleason score 7; postoperatively, 47% had extraprostatic extension disease, 36% had positive margin, and 22% had Gleason Score 8-10. Nomograms were developed for the predicted probabilities of having the indications of adjuvant radiation therapy (pathologically extraprostatic extension disease or positive margin(s), or Gleason Score 8-10, respectively). The calibration curve for probabilities showed good agreement between prediction by nomogram and actual observation. The C-index of the nomograms for predicting for extraprostatic extension disease, or positive margin(s), or Gleason Score 8-10 were 0.707, 0.659, 0.897, respectively. The risk of having one of the indications of adjuvant radiation therapy increased with increases in predictors except for clinical T stage for predicting Gleason Score 8-10 (P = 0.25). Using clinic-pathological information, we produced nomograms which may accurately predict the probabilities of having indications for adjuvant radiation therapy after RP. This nomogram may help individualize initial treatment options.

The P.R.OS.T.A.T.E Nomogram for the Preoperative Prediction of Clinical Efficacy of Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia Patients.

Nomogram predicting the efficacy of transurethral surgery in benign prostatic hyperplasia patients

A Novel Nomogram for Identifying the Patients at Risk for Rapid Progression of Advanced Hormone-Sensitive Prostate Cancer

A Nomogram for Accurately Predicting the Pathological Upgrading of Prostate Cancer, Based on 68 Ga-PSMA PET/CT.

A Reliable Nomogram is Identified to Predict the Probabilities of Having Indications for Adjuvant Prostatic Radiation Therapy

Predictive Factors for Tissue Inflammation in Patients with Benign Prostatic Hyperplasia: A Clinical Prediction Study

The Potential of a Nomogram Combined PI-RADS V2.1 and Contrast-Enhanced Ultrasound (CEUS) to Reduce Unnecessary Biopsies in Prostate Cancer Diagnostics

Construction and Validation of a Clinical Predictive Nomogram for Improving the Cancer Detection of Prostate Naive Biopsy Based on Chinese Multicenter Clinical Data

Predictive Value of Postoperative Ultrasonographic Parameters Regarding the Outcome after TURP for Patients with Symptomatic BPH

Development and Validation of a Preoperative Nomogram for Predicting Positive Surgical Margins after Laparoscopic Radical Prostatectomy

Nomogram predicting early urinary incontinence after radical prostatectomy

A Nomogram Predicting Re-Operation Due to Secondary Hemorrhage after Monopolar Transurethral Resection of Prostate

Nomogram for predicting the overall survival of patients with early-onset prostate cancer: A population-based retrospective study

Survival Analysis and a Novel Nomogram Model for Progression-Free Survival in Patients with Prostate Cancer

Integration of Multiparameter MRI into Conventional Pretreatment Risk Factors to Predict Positive Surgical Margins after Radical Prostatectomy.

Diagnostic Performance of a Nomogram Incorporating Cribriform Morphology for the Prediction of Adverse Pathology in Prostate Cancer at Radical Prostatectomy

Nomogram Predicting Survival to Assist Decision-Making of Radical Prostatectomy in Patients with Metastatic Prostate Cancer.

Establishment of a nomogram for predicting positive repeat prostate biopsy in patients with total PSA 4 to 10 ng/ml

Nomograms for Predicting Gleason Upgrading in a Contemporary Chinese Cohort Receiving Radical Prostatectomy after Extended Prostate Biopsy: Development and Internal Validation

The Prognostic Nomogram for PSA-incongruent Low-Risk Prostate Cancer Treated by Radical Prostatectomy

A Novel Nomogram Based on Initial Features to Predict BPH Progression